MARKET

NGEN

NGEN

Nervgen Pharma Corp
NASDAQ
3.880
+0.050
+1.31%
After Hours: 3.960 +0.08 +2.06% 19:39 02/06 EST
OPEN
3.890
PREV CLOSE
3.830
HIGH
4.025
LOW
3.840
VOLUME
146.21K
TURNOVER
--
52 WEEK HIGH
6.30
52 WEEK LOW
1.500
MARKET CAP
307.34M
P/E (TTM)
-14.9116
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NGEN last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at NGEN last week (0119-0123)?
Weekly Report · 01/26 09:06
Ten new option listings and two option delistings on January 22nd
TipRanks · 01/22 13:36
Weekly Report: what happened at NGEN last week (0112-0116)?
Weekly Report · 01/19 09:06
Weekly Report: what happened at NGEN last week (0105-0109)?
Weekly Report · 01/12 09:06
NERVGEN PHARMA BEGINS TRADING ON NASDAQ TODAY
Reuters · 01/08 11:30
Weekly Report: what happened at NGENF last week (1229-0102)?
Weekly Report · 01/05 09:06
Weekly Report: what happened at NGENF last week (1222-1226)?
Weekly Report · 12/29/2025 09:06
More
About NGEN
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.

Webull offers NervGen Pharma Corp stock information, including NASDAQ: NGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGEN stock methods without spending real money on the virtual paper trading platform.